Barry Palte

Barry Palte is a seasoned executive with extensive leadership experience across various sectors, including investment, biotechnology, and social impact. Currently serving as Chairman of EQ Capital Partners, GPN Vaccines, NewWave Biotech, and Impact Rooms, Barry focuses on leveraging ethical partnerships and innovative technologies to address global challenges such as health crises and food security. As a founding director of GPN Vaccines, Barry is integral to developing a vaccine for pneumococcal disease, while also holding positions on advisory boards and committees for organizations like MustGrow Biologics and the Extreme Tech Challenge. Barry's educational background includes a Bachelor of Business Science with first-class honors from the University of Cape Town and fellowships from the Institute and Faculty of Actuaries and the Institute of Actuaries of Australia.